Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice
Authors
Keywords
-
Journal
MUSCLE & NERVE
Volume 47, Issue 1, Pages 72-80
Publisher
Wiley
Online
2012-05-23
DOI
10.1002/mus.23465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis
- (2012) Stefania Momi et al. CARDIOVASCULAR RESEARCH
- Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations
- (2011) Donald G. Pittman et al. AMERICAN JOURNAL OF CARDIOLOGY
- Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle
- (2011) Giulia Maria Camerino et al. BIOCHEMICAL PHARMACOLOGY
- Statin myopathy: A common dilemma not reflected in clinical trials
- (2011) G. FERNANDEZ et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Statin-induced myopathy: a review and update
- (2011) Thura T Abd et al. Expert Opinion On Drug Safety
- Prevalence and risk factors of muscle complications secondary to statins
- (2011) Khalid El-Salem et al. MUSCLE & NERVE
- Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
- (2011) Amy Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy
- (2011) Clara Sciorati et al. PHARMACOLOGICAL RESEARCH
- Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans
- (2010) Clara Sciorati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Management of the Patient with Statin Intolerance
- (2010) Byron F. Vandenberg et al. Current Atherosclerosis Reports
- The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages
- (2010) Angela Amoruso et al. PHARMACOLOGICAL RESEARCH
- Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy
- (2009) Claudia Colussi et al. FASEB JOURNAL
- Nitric oxide and repair of skeletal muscle injury
- (2009) Lidiane Isabel Filippin et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Molecular basis of statin-associated myopathy
- (2008) Christos Vaklavas et al. ATHEROSCLEROSIS
- New insights into mechanisms of statin-associated myotoxicity
- (2008) P SIRVENT et al. CURRENT OPINION IN PHARMACOLOGY
- Cannabinoid Type 1 Receptor Blockade Promotes Mitochondrial Biogenesis Through Endothelial Nitric Oxide Synthase Expression in White Adipocytes
- (2008) L. Tedesco et al. DIABETES
- Supplemental nitric oxide augments satellite cell activity on cultured myofibers from aged mice
- (2008) Jenna L. Betters et al. EXPERIMENTAL GERONTOLOGY
- Prevalence of Musculoskeletal Pain and Statin Use
- (2008) Catherine Buettner et al. JOURNAL OF GENERAL INTERNAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More